9 Meters Biopharma : Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short ...

Retrieved on: 2021-06-14 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

9 Meters Biopharma : Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short .... View article details on hiswai:

Excerpt

RALEIGH, NC / ACCESSWIRE / June 14, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage biotechnology company focused on rare ...

Article found on: www.marketscreener.com